A detailed history of Angeles Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Angeles Investment Advisors, LLC holds 16,847 shares of PFE stock, worth $450,151. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,847
Previous 16,847 -0.0%
Holding current value
$450,151
Previous $471,000 3.4%
% of portfolio
0.03%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $92,199 - $108,040
-3,650 Reduced 17.81%
16,847 $471,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $38,705 - $44,446
1,495 Added 7.87%
20,497 $568,000
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $13,430 - $17,445
514 Added 2.78%
19,002 $547,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $23,489 - $27,457
-732 Reduced 3.81%
18,488 $613,000
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $52,085 - $60,261
1,442 Added 8.11%
19,220 $704,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $407,095 - $529,978
10,335 Added 138.86%
17,778 $725,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $310,745 - $405,643
7,443 New
7,443 $381,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $444,049 - $550,233
-9,706 Reduced 59.23%
6,680 $346,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $213,211 - $316,050
5,160 Added 45.96%
16,386 $968,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $440,620 - $566,014
11,226 New
11,226 $483,000
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $244,538 - $286,899
-7,702 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $231,984 - $281,431
7,702 New
7,702 $252,000
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $159,233 - $227,510
-5,891 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$32.49 - $42.13 $191,398 - $248,187
5,891 New
5,891 $212,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Angeles Investment Advisors, LLC Portfolio

Follow Angeles Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Angeles Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Angeles Investment Advisors, LLC with notifications on news.